An affiliate of New York-based private investment firm SK Capital Partners began negotiations to acquire LISI Group’s medical division (Lisi Medical).

Lisi Medical is a Neyron, France-based medtech contract development and manufacturing organization (CDMO) that produces high-precision metal components and assemblies for medical device original equipment manufacturers (OEMs). The company’s portfolio spans instruments used in minimally invasive and robotic-assisted surgery, as well as orthopedic implants.

SK Capital principal Josh Lieberman said Lisi Medical’s deep engineering heritage and cutting-edge manufacturing technologies make it an attractive partner to serve the world’s largest medtech OEMs.

“Under LISI Group’s ownership, the company has made significant investments to increase automation, expand production capacity, and add capabilities to support the growth of its customers,” Lieberman told the press. “We look forward to working with Lisi Medical’s management team to accelerate the Company’s growth by expanding with existing and new customers and continuing to add new capabilities both organically and through M&A.

LISI Group CEO Emmanuel Viellard said the company looks forward to partnering with SK Capital to advance its next development phase.

“Their strong track record in the life sciences sector and proven experience in France provide the essential strategic foresight and financial power to support the company going forward,” Viellard said. “This will also empower Lisi Medical to expand its offerings and capabilities, while solidifying its standing as a top-tier partner for leading medtech OEMs. We are confident this transaction will be beneficial to all stakeholders of Lisi Medical, be it employees, clients or suppliers.”

The transaction is anticipated to close in the second half of this year, pending approval from antitrust and foreign direct investment control authorities, as well as information and consultation processes with relevant representative bodies.